Pacira BioSciences (PCRX) Raw Materials (2011 - 2014)

Pacira BioSciences' Raw Materials history runs 4 years deep, the most recent figure standing at $7.4 million for Q2 2014.

• On a quarterly basis, Raw Materials rose 115.03% year-over-year to $7.4 million in Q2 2014; TTM through Jun 2014 was $7.4 million, a 115.03% increase from a year earlier, with the FY2013 full-year figure at $5.3 million, up 29.63% from the prior year.
• Raw Materials improved to $7.4 million in Q2 2014 per PCRX's latest filing, from $5.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $7.4 million in Q2 2014 and bottomed at $862000.0 in Q4 2011.
• The 4-year median for Raw Materials is $3.8 million (2012), against an average of $3.9 million.
• Across the five-year window, Raw Materials surged 373.43% in 2012 and gained 2.64% in 2013, its largest moves.
• Year by year, Raw Materials stood at $862000.0 in 2011, then jumped by 373.43% to $4.1 million in 2012, then climbed by 29.63% to $5.3 million in 2013, then soared by 39.3% to $7.4 million in 2014.
• Per Business Quant, the three latest PCRX Raw Materials figures stand at $7.4 million (Q2 2014), $5.3 million (Q4 2013), and $3.4 million (Q2 2013).